A health care executive says many current transparency efforts leave patients in a fog.

Eighteen percent of those living on the West Coast reported a plan to spend more, compared to only 10% of Northeasterners.

Many of the platform positions advocated by the Biden-Harris team do not directly affect employer-sponsored health plans but will have indirect implications.

It's the departing Trump administration's most ambitious effort to illuminate the complex system of prescription drug pricing.